Published in Lancet on August 13, 1988
Plasma cortisol and progression of dementia in subjects with Alzheimer-type dementia. Am J Psychiatry (2006) 2.05
Cognitive function, dementia and type 2 diabetes mellitus in the elderly. Nat Rev Endocrinol (2011) 1.92
Unravelling the pathophysiology of delirium: a focus on the role of aberrant stress responses. J Psychosom Res (2008) 1.72
What is the functional significance of chronic stress-induced CA3 dendritic retraction within the hippocampus? Behav Cogn Neurosci Rev (2006) 1.26
Neuropathology of stress. Acta Neuropathol (2013) 1.14
At the extreme end of the psychoneuroimmunological spectrum: delirium as a maladaptive sickness behaviour response. Brain Behav Immun (2012) 1.11
Current Challenges for the Early Detection of Alzheimer's Disease: Brain Imaging and CSF Studies. J Clin Neurol (2009) 1.06
Chronic stress enhances ibotenic acid-induced damage selectively within the hippocampal CA3 region of male, but not female rats. Neuroscience (2004) 1.03
The Douglas Hospital Longitudinal Study of Normal and Pathological Aging: summary of findings. J Psychiatry Neurosci (2005) 0.95
Metyrapone reveals that previous chronic stress differentially impairs hippocampal-dependent memory. Stress (2001) 0.92
Cerebrospinal fluid cortisol levels are higher in patients with delirium versus controls. BMC Res Notes (2010) 0.89
Cerebrospinal fluid biomarkers of Alzheimer's disease in healthy elderly. Front Biosci (Landmark Ed) (2013) 0.89
Glucocorticoid hormone (cortisol) affects axonal transport in human cortex neurons but shows resistance in Alzheimer's disease. Br J Pharmacol (2004) 0.86
Concentration dependent actions of glucocorticoids on neuronal viability and survival. Dose Response (2006) 0.86
Local amplification of glucocorticoids in the aging brain and impaired spatial memory. Front Aging Neurosci (2012) 0.85
Perceived Stress Is Differentially Related to Hippocampal Subfield Volumes among Older Adults. PLoS One (2016) 0.75
Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology (1998) 26.77
The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry (1982) 10.83
Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects. J Cereb Blood Flow Metab (1990) 6.62
Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. JAMA (2001) 5.13
Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse (1993) 4.13
Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor. Nature (1996) 4.04
Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease. Neurology (2007) 3.97
Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia. Science (1993) 3.88
The histological validation of post mortem magnetic resonance imaging-determined hippocampal volume in Alzheimer's disease. Neuroscience (2000) 3.40
Hippocampal formation glucose metabolism and volume losses in MCI and AD. Neurobiol Aging (2001) 3.25
Stress may add bite to appetite in women: a laboratory study of stress-induced cortisol and eating behavior. Psychoneuroendocrinology (2001) 2.96
A full genome search in multiple sclerosis. Nat Genet (1996) 2.96
Changes in brain glucose metabolism in cocaine dependence and withdrawal. Am J Psychiatry (1991) 2.89
Atrophy of the medial occipitotemporal, inferior, and middle temporal gyri in non-demented elderly predict decline to Alzheimer's disease. Neurobiol Aging (2000) 2.80
Frequency of hippocampal formation atrophy in normal aging and Alzheimer's disease. Neurobiol Aging (1997) 2.68
Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer disease. Neurology (2008) 2.66
Inhibition of monoamine oxidase B in the brains of smokers. Nature (1996) 2.62
Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease. Ann Neurol (1998) 2.48
The radiologic prediction of Alzheimer disease: the atrophic hippocampal formation. AJNR Am J Neuroradiol (1993) 2.44
Stress and body shape: stress-induced cortisol secretion is consistently greater among women with central fat. Psychosom Med (2001) 2.30
Hippocampal volume losses in minimally impaired elderly. Lancet (1995) 2.26
Reduced hippocampal metabolism in MCI and AD: automated FDG-PET image analysis. Neurology (2005) 2.24
Close relationship between systemic lupus erythematosus and thrombotic thrombocytopenic purpura in childhood. Arthritis Rheum (1999) 2.23
Long-term frontal brain metabolic changes in cocaine abusers. Synapse (1992) 2.16
Global Deterioration Scale (GDS). Psychopharmacol Bull (1988) 2.14
Single nucleotide polymorphisms in multiple novel thrombospondin genes may be associated with familial premature myocardial infarction. Circulation (2001) 2.09
Altered glucose metabolism in microvessels from patients with Alzheimer's disease. Ann Neurol (1989) 2.08
Metabolic trapping as a principle of oradiopharmaceutical design: some factors resposible for the biodistribution of [18F] 2-deoxy-2-fluoro-D-glucose. J Nucl Med (1978) 2.07
Early marker for Alzheimer's disease: the atrophic hippocampus. Lancet (1989) 2.02
A fluorinated glucose analog, 2-fluoro-2-deoxy-D-glucose (F-18): nontoxic tracer for rapid tumor detection. J Nucl Med (1980) 2.01
Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography. Neurology (1982) 1.99
Visible burrow system as a model of chronic social stress: behavioral and neuroendocrine correlates. Psychoneuroendocrinology (1995) 1.92
Alzheimer disease: measuring loss of cerebral gray matter with MR imaging. Radiology (1991) 1.92
MRI of entorhinal cortex in mild Alzheimer's disease. Lancet (1999) 1.86
Is [1-11C]putrescine useful as a brain tumor marker? J Nucl Med (1992) 1.80
Brain monoamine oxidase A inhibition in cigarette smokers. Proc Natl Acad Sci U S A (1996) 1.78
Relationships between regional neuronal loss and neurofibrillary changes in the hippocampal formation and duration and severity of Alzheimer disease. J Neuropathol Exp Neurol (1997) 1.67
Effects of chronic cocaine abuse on postsynaptic dopamine receptors. Am J Psychiatry (1990) 1.66
The behavioural neurology assessment. Can J Neurol Sci (2005) 1.62
Prevalence of primitive reflexes and Parkinsonian signs in dementia. Can J Neurol Sci (2010) 1.62
CT diagnostic features of Alzheimer disease: importance of the choroidal/hippocampal fissure complex. AJNR Am J Neuroradiol (1990) 1.62
Gender differences in age-related changes in HPA axis reactivity. Psychoneuroendocrinology (2001) 1.60
Intersubject variability of brain glucose metabolic measurements in young normal males. J Nucl Med (1994) 1.54
Subordination stress: behavioral, brain, and neuroendocrine correlates. Behav Brain Res (1993) 1.54
A glial protein specific for the nervous system. Proc Natl Acad Sci U S A (1966) 1.51
Clustering and switching on verbal fluency tests in Alzheimer's and Parkinson's disease. J Int Neuropsychol Soc (1998) 1.49
Hippocampal atrophy in normal aging. An association with recent memory impairment. Arch Neurol (1993) 1.49
Evidence for a mixed lattice in microtubules reassembled in vitro. J Mol Biol (1980) 1.48
Diminished cerebral metabolic response to motor stimulation in schizophrenics: a PET study. Eur Arch Psychiatry Clin Neurosci (1994) 1.48
Ocular lesions associated with HIV infection in India: a series of 100 consecutive patients evaluated at a referral center. Am J Ophthalmol (2000) 1.47
Shwachman syndrome: phenotypic manifestations of sibling sets and isolated cases in a large patient cohort are similar. J Pediatr (1999) 1.47
Further observations on the doubling time of human chorionic gonadotropin in early asymptomatic pregnancies. Fertil Steril (1990) 1.43
Donepezil preserves cognition and global function in patients with severe Alzheimer disease. Neurology (2007) 1.43
The symphysis pubis. Anatomic and pathologic considerations. Clin Orthop Relat Res (1986) 1.42
Serial [18F]N-methylspiroperidol PET studies to measure changes in antipsychotic drug D-2 receptor occupancy in schizophrenic patients. Biol Psychiatry (1988) 1.40
Patterns of motor impairement in normal aging, mild cognitive decline, and early Alzheimer's disease. J Gerontol B Psychol Sci Soc Sci (1997) 1.39
Volumetric analysis of the pre-frontal regions: findings in aging and schizophrenia. Psychiatry Res (2001) 1.38
Serendipity in diagnostic imaging: magnetic resonance imaging of the breast. J Natl Cancer Inst (1998) 1.38
Building communities that promote successful aging. West J Med (1997) 1.34
Hippocampal atrophy in early Alzheimer's disease: anatomic specificity and validation. Psychiatr Q (1993) 1.33
Hippocampal formation size predicts declining memory performance in normal aging. Neurology (1996) 1.33
Brain-derived neurotrophic factor as a model system for examining gene by environment interactions across development. Neuroscience (2009) 1.33
Topography of cross-sectional and longitudinal glucose metabolic deficits in Alzheimer's disease. Pathophysiologic implications. Arch Neurol (1992) 1.33
Work in progress: [18F] fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain. Radiology (1982) 1.31
Atrophy rate in medial temporal lobe during progression of Alzheimer disease. Neurology (2004) 1.31
Hippocampal formation size in normal human aging: a correlate of delayed secondary memory performance. Learn Mem (1999) 1.31
Behavioral and endocrine change following chronic predatory stress. Physiol Behav (1998) 1.31
Mapping cocaine binding sites in human and baboon brain in vivo. Synapse (1989) 1.29
Amnesia after anterior communicating artery aneurysm rupture. Neurology (1984) 1.26
Effect of chronic stress and exogenous glucocorticoids on regional fat distribution and metabolism. Physiol Behav (1992) 1.26
Mapping human brain monoamine oxidase A and B with 11C-labeled suicide inactivators and PET. Science (1987) 1.26
Is there evidence of birth control in late Imperial China? Popul Dev Rev (2001) 1.25
Analyses of glucans from cariogenic and mutant Streptococcus mutans. Infect Immun (1978) 1.24
Striatal binding of the PET ligand 11C-raclopride is altered by drugs that modify synaptic dopamine levels. Synapse (1993) 1.24
Assessment of regional cerebral perfusion by 99Tcm-HMPAO SPECT in chronic fatigue syndrome. Nucl Med Commun (1992) 1.23
Measuring age-related changes in dopamine D2 receptors with 11C-raclopride and 18F-N-methylspiroperidol. Psychiatry Res (1996) 1.22
Slow recovery of human brain MAO B after L-deprenyl (Selegeline) withdrawal. Synapse (1994) 1.22
Structural studies on porcine brain tubulin in extended sheets. J Mol Biol (1977) 1.21
Brain interactions in chronic schizophrenics under resting and activation conditions. Schizophr Res (1991) 1.20
Decreased brain metabolism in neurologically intact healthy alcoholics. Am J Psychiatry (1992) 1.19
GABAergic inhibition of endogenous dopamine release measured in vivo with 11C-raclopride and positron emission tomography. J Neurosci (1992) 1.19
Cortisol differentially affects memory in young and elderly men. Behav Neurosci (2001) 1.19
Leukoencephalopathy in normal and pathologic aging: 2. MRI of brain lucencies. AJNR Am J Neuroradiol (1986) 1.18
Anhydrous F-18 labeled eslemental flurine for radiopharmaceutical preparation. J Nucl Med (1980) 1.18
Popular diets: correlation to health, nutrition, and obesity. J Am Diet Assoc (2001) 1.17
In vivo structural studies of the hippocampus in normal aging and in incipient Alzheimer's disease. Ann N Y Acad Sci (1996) 1.17
Negative symptoms and hypofrontality in chronic schizophrenia. Arch Gen Psychiatry (1992) 1.17